Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study
Authors:
- E. López-MirandaELE. López-Miranda
- P. Tolosa-OrtegaPTP. Tolosa-Ortega
- M.A. Perelló-MartorellMPM.A. Perelló-Martorell
- L. Sánchez-LorenzoLSL. Sánchez-Lorenzo
- C. Hinojo-GonzálezCHC. Hinojo-González
- S. ServitjaSSS. Servitja
- S. Recalde-PenabadSRS. Recalde-Penabad
- C. Olier-GárateCOC. Olier-Gárate
- J.A. GuerreroJGJ.A. Guerrero
- S. García-VicenteSGS. García-Vicente
- L. MinaLML. Mina
- D. Alcalá-LópezDAD. Alcalá-López
Open Access
- 18 January 2025
- journal article
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 7
Abstract
No abstract availableKeywords
Funding Information
- Daiichi-Sankyo
- AstraZeneca España
This publication has 30 references indexed in Scilit:
- LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)Annals of Oncology, 2024
- The DERMACLEAR study: Verification results of a natural language processing system in dermatologyJEADV Clinical Practice, 2023
- An open source corpus and automatic tool for section identification in Spanish health recordsJournal of Biomedical Informatics, 2023
- Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancersBritish Journal of Cancer, 2023
- Natural Language Processing in Electronic Health Records in relation to healthcare decision-making: A systematic reviewComputers in Biology and Medicine, 2023
- Evolution of low HER2 expression between early and advanced-stage breast cancerEuropean Journal of Cancer, 2022
- Evolution of HER2-low expression from primary to recurrent breast cancernpj Breast Cancer, 2021
- Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound examsNature Communications, 2021
- Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohortnpj Breast Cancer, 2021
- Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institutionLaboratory Investigation, 2020